At baseline, individuals with dyslipidemia exhibited significantly lower SHBG levels compared to those without dyslipidemia (P < 0.001), with median values of 65.2 nmol/L (48.3–86.4) and 80.6 nmol/L (60.4–99.1), respectively. The gene discussed is SHBG; the disease is metabolic syndrome.